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Summary
 
Cutaneous gene (DNA) bombardment results in substantial expression of the encoded antigen
in the epidermal layer as well as detectable expression in dendritic cells (DC) in draining lymph
nodes (LNs). Under these conditions, two possible modes of DC antigen presentation to naive
CD8
 
1
 
 T cells might exist: (
 
a
 
) presentation directly by gene-transfected DC trafficking to local
lymph nodes, and (
 
b
 
) cross-presentation by untransfected DC of antigen released from or asso-
ciated with transfected epidermal cells. The relative contributions of these distinct modes of an-
tigen presentation to priming for cytotoxic T cell (CTL) responses have not been clearly estab-
lished. Here we show that LN cells directly expressing the DNA-encoded antigen are rare; 24 h
after five abdominal skin bombardments, the number of these cells does not exceed 50–100
cells in an individual draining LN. However, over this same time period, the total number of
CD11c
 
1
 
 DC increases more than twofold, by an average of 20,000–30,000 DC per major
draining node. This augmentation is due to gold bombardment and is independent of the pres-
ence of plasmid DNA. Most antigen-bearing cells in the LNs draining the site of DNA delivery
appear to be DC and can be depleted by antibodies to an intact surface protein encoded by
cotransfected DNA. This finding of predominant antigen presentation by directly transfected
cells is also consistent with data from studies on cotransfection with antigen and CD86-encod-
ing DNA, showing that priming of anti-mutant influenza nucleoprotein CTLs with a single
immunization is dependent upon coexpression of the DNAs encoding nucleoprotein and B7.2
in the same cells. These observations provide insight into the relative roles of direct gene ex-
pression and cross-presentation in CD8
 
1
 
 T cell priming using gene gun immunization, and in-
dicate that augmentation of direct DC gene expression may enhance such priming.
Key words: dendritic cells • DNA immunization • cytotoxic T lymphocytes • gene gun • 
antigen presentation
 
S
 
ince the discovery that plasmid DNA encoding a pro-
tein antigen can serve as an effective immunogen,
DNA-based vaccination has become an attractive alterna-
tive to recombinant live vector immunization strategies. By
direct injection, both skeletal muscles and skin have dem-
onstrated the ability to take up and express DNA-encoded
sequences without a special delivery system (1, 2). Alterna-
tively, gold particles coated with DNA can be physically
delivered into living tissues using a helium-powered gene
delivery device, the “gene gun” (3). All of these routes of
DNA delivery have been shown to successfully induce
both cellular and humoral immunity in several antigen sys-
tems (4–7). Such plasmid DNA immunization can evoke
immune responses dependent on both MHC class I and
class II molecule–mediated antigen presentation to CD8
 
1
 
and CD4
 
1
 
 T cells, respectively. The addition of DNAs en-
coding various cytokines or costimulatory molecules ad-
mixed with DNA encoding antigens serves to enhance the
magnitude and type of desired immune responses (8). Us-
ing this technology, protective immunity in several virus
and cancer disease models has been demonstrated in animal
systems.
The exact mechanism by which injected or particle-
coated DNA leads to antigen presentation capable of elicit-
ing a T cell immune response has yet to be fully defined.
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CD8
 
1
 
 CTL responses induced by either gene gun or intra-
muscular inoculations appear to be initiated by bone mar-
row–derived APCs, as shown in recent experiments per-
formed in parent-into-F1 bone marrow–reconstituted mice
(9–12). Condon et al. have demonstrated that some skin-
derived dendritic cells (DC)
 
1
 
 that subsequently localize in
the draining LNs are directly transfected after cutaneous
genetic immunization with the gene gun (13). However,
after gene gun bombardment of the abdominal epidermis,
keratinocytes are the main cell type found to be expressing
the DNA-encoded proteins (14). Similarly, striated muscle
cells are the predominant transfected, antigen-positive cells
after intramuscular injection (15).
It remains unclear whether priming of naive CD8
 
1
 
 T
cells depends on antigen produced by the transfected myo-
cytes or keratinocytes that is taken up, processed, and pre-
sented by professional APCs migrating to the draining lym-
phoid tissue, by the direct transfection of and antigen
production and presentation by professional APCs, or by
both mechanisms. Surgical ablation experiments have sug-
gested that there may be a different contribution of local
tissue antigen expression, depending on the route of im-
munization (16). For example, the muscle bundle can be
removed within 10 min of DNA injection without any ef-
fect on the longevity and magnitude of the humoral and
CTL responses (16). On the other hand, excision of the
epidermal site 24 h after gene gun bombardment abrogated
the induction of CTL responses, suggesting an immune de-
pendence on the transfected skin cells (16). However,
Klinman et al. showed that gene gun immunization is inde-
pendent of cells in the bombarded tissue site with regard to
induction of memory T cell responses (17). Casares et al.
have recently demonstrated that the direct uptake of DNA
by draining LN-derived DC, but not B cells, resulted in ef-
fective presentation to MHC class II–restricted T cells (18).
Antigen released from cultured transfected muscle cells can
also generate ligands able to activate MHC class II–restricted
T cells when supernatants are pulsed onto DC (18).
Here we further explore the cellular mechanisms respon-
sible for the priming of CD8
 
1
 
 T cells after epidermal DNA
immunization. First, we determined the number of directly
transfected cells found in the draining LNs after immuniza-
tion as well as the total number of LN-migrating DC in-
duced by this procedure. Second, we evaluated MHC class
I–dependent presentation of DNA-encoded determinants
by directly transfected versus nontransfected migrating DC.
Third, we used a mutant form of the nucleoprotein (NP)
influenza antigen that requires coadministration of DNA
encoding CD86 to examine whether the same cells re-
quired coexpression of the antigen and costimulatory mol-
ecule to prime naive CD8
 
1
 
 T cells. These studies all sug-
gest that the predominant contribution to priming for
CD8
 
1
 
 CTL responses after DNA immunization using the
gene gun approach involves the small number of directly
transfected, migrating DC rather than the much larger
number of migrating DC that could potentially present an-
tigen via a cross-priming mechanism after antigen expres-
sion by epidermal cells.
 
Materials and Methods
 
Animals.
 
Female BALB/c mice were obtained at 6–8 wk of
age (Charles River Laboratories, Quebec, Canada), and female
C57BL/6 mice were obtained at 6–10 wk of age (Animal Produc-
tion Colonies, Frederick Cancer Research Facility, National Insti-
tutes of Health, Frederick, MD). All procedures with animals were
carried out in accordance with institutionally approved protocols.
 
Cell Lines.
 
The P815 cell line is a murine mastocytoma ob-
tained from the American Type Culture Collection, Rockville,
MD (TIB 64), cultured in RPMI 1640 medium supplemented
with 10% FCS, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin,
and 2 mM 
 
l
 
-glutamine.
 
Plasmids and Peptides.
 
A plasmid encoding the 
 
Escherichia coli
LacZ
 
 gene under the control of the human CMV intermediate-
early promoter, designated pCMV/
 
b
 
-gal, was provided by J.
Haynes (Agracetus Inc., Middleton, WI [5]). T4TM is a plasmid
encoding human CD4 under the control of the CMV promoter
in a CDM8 plasmid. Plasmid DNA was amplified in the 
 
E
 
.
 
 coli
 
DH5
 
a
 
 bacterial strain and purified through large scale plasmid
preparations, using the cesium chloride purification method. The
isolation, by reverse transcriptase PCR amplification, and cloning
of a nonimmunogenic mutant of influenza nucleoprotein (NPo)
and mouse CD86 (B7.2) used in the immunization constructs
have been previously described (19). The NPo/B7.2 colinear ex-
pression cassette contains NPo and B7.2 in tandem, each gene
separately driven by its own CMV promoter and terminated by a
bovine growth hormone polyA signal (19). This plasmid DNA
was amplified in the JM109 bacterial strain and purified through
large scale plasmid preparations, using endotoxin-free Mega Prep
columns (QIAGEN, Inc., Chatsworth, CA). The H-2K
 
d
 
–restricted
peptide NP147-155 (TYQRTRALV) from the NP of influenza
virus A/PR/8/34 was synthesized and purified commercially
(Alberta Peptide Institute, Alberta, Canada).
 
Gene Gun Delivery of DNA.
 
For experiments involving 
 
b
 
-gal,
sodium pentobarbital–anesthetized C57BL/6 mice received one
to five nonoverlapping abdominal deliveries of DNA-coated gold
beads (2 
 
m
 
m) using the Accell gene gun (Agracetus, Inc.) at a
helium discharge pressure of 350–400 psi. Plasmid DNA was
coated onto gold particles as described (5). 0.5 mg of gold beads
was coated with 1 
 
m
 
g of pCMV/
 
b
 
-gal or control plasmid (per
one shot); when cocoating pCMV/
 
b
 
-gal and T4TM (human
[h]CD4) DNAs, 0.5 
 
m
 
g of each plasmid were admixed.
For experiments involving induction of anti-NPo CTLs,
Avertin-anesthetized BALB/c mice received six abdominal deliv-
eries of DNA-coated gold beads (1 
 
m
 
m) using a gene gun (Bio-
Rad Laboratories, Mississauga, Ontario, Canada) at a helium dis-
charge pressure of 400–450 psi. Plasmid DNA was coated onto
gold particles as described (20). Groups of mice received the fol-
lowing gene gun bombardments: the NPo plus B7.2 (colinear)
group received six nonoverlapping shots of 0.5 mg of gold beads
coated with 0.125 
 
m
 
g of colinear NPo/B7.2 construct; the NPo
and B7.2 (cocoat) group received six shots of 0.5 mg gold beads
cocoated with 0.125 
 
m
 
g each of B7.2 and NPo; the NPo plus
B7.2 (overlap) group was given six shots at three separate abdom-
inal sites, with two shots per site, one consisting of 0.5 mg gold
beads coated with 0.125 
 
m
 
g of B7.2, and another with 0.5 mg gold
 
1
 
Abbreviations used in this paper:
 
 DC, dendritic cell(s); GFP, green fluores-
cent protein; NP, nucleoprotein. 
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beads coated with 0.125 
 
m
 
g of NPo. Mice were assayed 3–4 wk later
for CTL priming using an in vitro restimulation assay (see below).
 
Collagenase Treatment of LNs and DC Enrichment.
 
Collagenase-
digested LNs were prepared as described previously (21), except
that in all steps after collagenase treatment, an EDTA-containing
buffer was used to prevent reassociation of T cells with DC (22).
For DC enrichment, suspended LN cells were layered over a me-
trizamide gradient column, centrifuged, and low density cells
(DC-enriched) and high density cells (DC-depleted) were col-
lected (23).
 
Flow Cytometry.
 
LN cells were incubated with an antibody
that blocks Ig binding to Fc
 
g
 
II and III receptors and then incu-
bated with N418 supernatant for 30 min at 4
 
8
 
C, washed with
PBS/5% FCS/0.1% sodium azide, and then incubated with PE-
or FITC-goat F(ab
 
9
 
)
 
2 
 
anti–hamster IgG, mouse/rat adsorbed
(Caltag Laboratories, Inc., Burlingame, CA) for 30 min at 4
 
8
 
C.
The cells were then washed and resuspended in the same medium
plus propidium iodide to allow exclusion of dead cells during
analysis. Stained cells were analyzed using a FACScan
 
Ò
 
 flow cy-
tometer (Becton Dickinson, Bedford, MA). Between 100,000
and 150,000 events were monitored per sample.
 
Staining for 
 
b
 
-gal Activity.
 
Draining LNs were snap frozen in
liquid nitrogen and stored at 
 
2
 
70
 
8
 
C. Frozen sections (10 
 
m
 
M)
were cut; every other section was mounted on glass slides to min-
imize counting the same stained cell twice, and the slides were
stored at 
 
2
 
70
 
8
 
C. For 
 
b
 
-galactosidase staining, frozen sections or
cells in 24-well plates were fixed in PBS/2% formaldehyde/0.2%
glutaraldehyde at 4
 
8
 
C for 7 min, washed in PBS, and incubated
with X-Gal substrate (1 mg/ml X-Gal in PBS/5 mM potassium
ferricyanide/5 mM potassium ferrocyanide/2 mM magnesium
chloride) at 37
 
8
 
C until positive cells (blue) appeared. Slides and
24-well plates were screened for positive cells using a Labophot
microscope and a TMS inverted microscope (both from Nikon
Inc., Melville, NY), respectively.
 
Depletion of Cell Subpopulations.
 
Suspended LN cells were in-
cubated for 30 min with the following mAbs (in supernatant
form): B21-2 (anti–I-A
 
b,d
 
, TIB-229; American Type Culture
Collection), NLDC-145 (anti–DEC-205 antigen [24]), F4/80
(anti–mouse macrophage, HB-198; American Type Culture Col-
lection), and RA3-3A1/6.1 (anti-B cell surface protein B220,
TIB-146; American Type Culture Collection). After incubation,
cells were washed, and antibody-coated cells were removed by
sheep anti–rat IgG–coupled magnetic beads (Dynabeads; Dynal
A.S., Oslo, Norway). The beads and cells were mixed at a ratio of
10:1 and incubated for 30 min with continuous slow rotation at
4
 
8
 
C, diluted, and beads/bead-bound cells were removed using a
magnet (Dynal A.S.). mAb supernatants and washing buffer con-
tained 5 mM EDTA (22). For depletion of human CD4
 
1
 
 LN
cells or DC-enriched LN cells, cells were treated as above except
that the mAb was OKT4 (anti–human CD4, CRL-8002; Ameri-
can Type Culture Collection) and the beads were coupled to
sheep anti–mouse IgG.
 
Stimulation of 
 
b
 
-gal–specific T Cell Clone.
 
A 
 
b
 
-gal–specific T
cell line that recognizes the K
 
b
 
-restricted sequence DAPIYTNV
corresponding to 
 
b
 
-gal 96–103 was provided by W.W. Overwijk
(National Institutes of Health, Bethesda, MD [25]). T cells (10
 
5
 
/
well) were incubated at different ratios with LN cells or DC-
enriched LN cells in U-bottomed 96-well plates for 18 h, after
which IFN-
 
g
 
 levels in the supernatant were measured using an
ELISA kit (Endogen, Inc., Woburn, MA).
 
CTL Lysis Assay.
 
4 wk after gene gun immunization, spleens
were harvested, and single cell suspensions were prepared. Spleen
cells from individual mice in each DNA-immunized group were
cultured for 7 d at 5 
 
3 
 
10
 
6
 
/ml in the presence of 2.5 
 
3 
 
10
 
6
 
/ml
syngeneic irradiated spleen cell stimulators prepulsed for 1 h with
the H-2K
 
d
 
–restricted epitope NP(147-155) at 0.1 
 
m
 
g/
 
m
 
l. CTLs
specific for NP(147-155) used in the target lysis experiments were
obtained from splenocytes of influenza-infected mice, which
were restimulated in vitro as above. Antigen-specific cell-medi-
ated cytotoxicity was assayed using P815 cells that had been la-
beled by incubation for 1 h at 37
 
8
 
C with 100 
 
m
 
Ci of Na
 
51
 
CrO
 
4
 
and concomitantly pulsed with 10 
 
m
 
M of the NP(147-155) pep-
tide. Washed target cells at 10
 
4
 
/well were incubated for 4 h in
triplicate at 37
 
8
 
C with serial dilutions of effector cells. Maximum
and spontaneous release were determined from wells containing
2% Triton X-100 or medium alone, respectively. Specific lysis
was calculated as (experimental 
 
51
 
Cr release 
 
2 
 
spontaneous 
 
51
 
Cr
release)/(maximum 
 
51
 
Cr release 
 
2 
 
spontaneous 
 
51
 
Cr release) 
 
3
 
100%. Nonspecific lysis was evaluated using unpulsed labeled
P815 cells. Previous experiments have shown that such unpulsed
cells give the same background lysis (
 
,
 
5%) as P815 cells pulsed
with an irrelevant peptide (A. Iwasaki, unpublished results).
 
Results and Discussion
 
The Total Number of DC in Draining LNs Doubles after
Gene Gun Particle Bombardment.
 
We first examined the
number of DC in LNs draining the site(s) of gene gun
bombardment compared with naive LNs. This was done
24 h after gene bombardment, as the number of DC and
antigen-carrying DC in draining LNs peaks between 24
and 48 h after skin contact with antigen (23, 26). After ab-
dominal gene gun delivery (five shots), draining inguinal
LNs contained twice the number of total nucleated cells as
naive LNs. LN cells were isolated using the collagenase
method to insure release of interdigitating DC and stained
with the N418 mAb against CD11c, then the number of
N418
 
1
 
 DC in the gate of large forward and side scatter was
determined. The total number of N418
 
1
 
 DC in draining
inguinal LNs was 2–2.5-fold more than their number in
naive inguinal LNs (Fig. 1 
 
A
 
). A smaller increase in nucle-
ated and dendritic cell number was seen in axillary and bra-
chial LNs, which also drain the abdominal skin (23), but
not in spleen (data not shown). The class II and CD80
(B7.1)/CD86 (B7.2) costimulatory phenotypes of the N418
 
1
 
DC in LNs draining the site(s) of bombardment compared
with those present in naive LNs were similar (data not
shown).
The enlargement of the LNs as well as the increase in the
number of DC was due to the bombardment process itself,
as delivery of gold particles lacking plasmid DNA resulted
in similar findings (Fig. 1 
 
B
 
). Thus, it is likely that cellular
(presumably inflammatory cytokine/chemokine) responses
to the physical insult of gold particle bombardment induces
the response in draining LNs. Consistent with this interpre-
tation, the cell number increase was proportional to the
number of shots (data not shown). The DC that appear in
the draining LNs are probably derived in large measure
from the bombarded skin area, given the proportionality
between their number and the skin surface subjected to
particle exposure, as well as the evidence for such migra-
tion from skin painted with fluorescent sensitizers (13, 23). 
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However, additional recruitment from circulating cells or
expansion from blood or local precursors cannot be ruled
out, especially given the overall increase in nucleated cells
that presumably arises from such sources.
 
Draining LNs Contain a Small Number of Directly Transfected
Cells after Biolistic Delivery of DNA.
 
Condon et al. have re-
ported that gene bombardment of skin results in directly
transfected cells in the draining LNs, and that these cells are
skin-derived DC, although the number of such cells was
not determined, nor was their possible role in T cell prim-
ing (13). Such directly transfected DC that migrate to the
draining LNs might produce the antigen internally and
process it very efficiently via the conventional class I path-
way for presentation to CD8
 
1
 
 T cells. We further explored
this issue by attempting to quantitate the number of such
directly transfected cells and their functional significance.
Mice received nonoverlapping abdominal deliveries (one,
two, and five shots) of gold beads coated with a 
 
b
 
-gal–encod-
ing plasmid. 24 h after immunization, draining LNs were
harvested and sectioned for analysis. Frozen sections of LN
were stained for 
 
b-gal activity. To assure accurate counting
of b-gal–positive cells, we analyzed between 100 and 200
alternate sections (10 mm cuts) per experimental group,
thus screening a total volume of one to two LNs. Because
b-gal is a cytoplasmic enzyme, only cells directly trans-
fected with the gene and producing the enzyme endoge-
nously have enough b-gal to yield a positive staining signal
under these conditions. Fig. 2 A shows that there is a linear
correlation between the number of nonoverlapping ab-
dominal deliveries and the number of b-gal–positive cells
in the draining inguinal LNs. Overall, the numbers are very
low and average z15 b-gal–positive cells in each inguinal
LN after one abdominal exposure to DNA-coated gold
particles. No b-gal–positive cells were observed in draining
LNs from unimmunized mice or mice bombarded with a
control plasmid. Inguinal LNs are the major draining LNs
after abdominal skin contact with antigen, but cells pre-
senting the antigen are also found in other skin-draining
LNs (23). The average of such positive cells in axillary and
brachial LNs for one delivery of DNA was less than in the
inguinal LNs (Fig. 2 B). In contrast to the few transfected
cells in the draining LNs, the epidermal layer in skin sec-
tions at the delivery site was practically all b-gal positive
(data not shown).
On average, the total number of directly transfected cells
in the skin-draining LNs after abdominal delivery did not
exceed 200 cells per mouse, as assessed by expression of a
sufficient amount of active b-gal to yield a highly visible
amount of reacted substrate. Some directly transfected cells
might make a small amount of protein below the detection
limit of this assay but sufficient for presentation and T cell
priming. However, positive cells showed strong staining
with very few if any faint positives, suggesting that the cat-
alytic activity of even a small number of b-gal molecules in
the cytoplasm of a cell is sufficient for detection. This
makes it unlikely that our estimate of directly transfected
cells is substantially below the actual number able to serve
Figure 1. Number of N4181 DC recruited to the draining LNs after
gene gun immunization. Groups of C57BL/6 mice (n 5 3–6) received
five abdominal deliveries of gold beads coated with different plasmids. 24 h
after bombardment, nucleated LN cells from draining inguinal nodes of
immunized or naive mice were isolated using the collagenase method and
pooled. FcgII and III receptors were blocked, and cells were stained with
N418 followed by PE-goat anti–hamster antibodies (adsorbed on mouse
and rat Ig). The number of N4181 cells was monitored by FACSÒ (.105
total cells/sample) and calculated per one draining LN (DLN) based on
the number of nucleated cells in the pooled LNs and the number of LNs
in each group. (A) Three different experiments (Exp.) comparing DC
number in inguinal LNs between naive mice and mice bombarded with
pCMV/b-gal. (B) Comparison of DC number in inguinal LNs among
naive mice and mice bombarded either with gold beads alone or with
gold beads coated with pCMV/b-gal or control plasmids (Mock 1, Mock
2). Mock 1, pCDNA3, which contains the ampicillin resistance gene.
Mock 2, Wrg7077, which contains the kanamycin resistance gene. Similar
results were obtained in another experiment.
Figure 2. Number of directly transfected (b-gal–positive) cells in
draining LNs. Groups of C57BL/6 mice (n 5 3) received nonoverlapping
abdominal deliveries (one, two, or five shots) of gold beads coated with
pCMV/b-gal. 24 h after bombardment, draining LNs were harvested,
pooled, and sectioned for analysis (A), or nucleated cells from the LNs
were pooled and plated, 106/well, into 24-well plates (B and C). Frozen
sections and 24-well plates were stained for b-gal activity. To assure accu-
rate enumeration of b-gal–positive cells, we (a) screened between 100
and 200 alternate serial sections (10 mm cuts) per each experimental group
to evaluate a tissue mass equal to one to two LNs (A) and (b) screened
wells containing cells from a total of two to three pooled LNs (B). No
cells showing strong uniform staining were observed in draining LNs
from unimmunized mice or mice bombarded with a control plasmid. The
results in A and B/C are from two different experiments. Similar results
were obtained in another experiment.1079 Porgador et al.
as functional APCs. Additional evidence that the small num-
ber of cells containing b-gal in the draining LNs express this
protein as a result of direct transfection comes from PCR de-
tection of plasmid DNA in LN cell suspensions (data not
shown). Although direct characterization of these few cells by
FACSÒ or immunohistochemical costaining has not been
successful, studies by other investigators of directly transfected
cells appearing in draining LNs after gene gun delivery of
green fluorescent protein (GFP)-encoding DNA or after skin
painting with fluorescent sensitizers have demonstrated
these migrating cells to be skin-derived DC (13). Given the
likelihood that such cells expressing the plasmid-encoded
antigen would be especially effective at processing and pre-
senting antigenic peptides in association with MHC class I
molecules, the question arose of whether these cells or the
larger number of migrating DC that might present antigen via
class I by processing of exogenous antigen from transfected
epidermal cells were responsible for sensitization of CD81
CTL precursors under these immunization conditions.
APCs Involved in Class I–restricted Presentation after Biolistic
Delivery of b-gal DNA Are Predominantly Directly Transfected
DC. We first tested what type of APCs in draining LNs
24 h after gene gun delivery of pCMV/b-gal into C57BL/6
mice presents a class I–restricted determinant. LN cells
were isolated using the collagenase method that allows re-
covery of CD81/DEC-2051 interdigitating DC and were
subjected to depletion of different cell subpopulations using
mAbs and magnetic beads. These cells were then incubated
with CD81 T cells from a CTL line specific for a b-gal–
derived determinant presented by Kb, and IFN-g secretion
by the T cells was measured (Fig. 3 A). Class II–positive
cells were essential for this presentation, but B cells and
macrophages were not. Depletion of DEC-2051 cells elim-
inated up to 70% of the presentation activity. As only
z50% of CD11c1 DC in the inguinal LNs express even
moderate levels of cell surface DEC-205 (data not shown,
and reference 27), these data suggest that DEC-205–surface
positive DC are especially effective at presentation of anti-
gen in association with MHC class I molecules after DNA
vaccination by gene gun. These data are consistent with the
conclusion that DC in the draining LNs are the primary
cell type bearing stimulatory levels of the b-gal determi-
nant associated with Kb after gene gun delivery of b-gal–
encoding plasmid.
We next analyzed whether the DC capable of this pre-
sentation acquired antigen from other transfected cells or
by direct gene expression. Gold particles were cocoated
with plasmid DNA encoding the human CD4 cell surface
molecule and with pCMV/b-gal DNA. Thus, directly
transfected DC will express human CD4 as a membrane
protein and should also present directly processed b-gal de-
terminants. C57BL/6 mice were immunized with five ab-
dominal deliveries of these cocoated beads, and 24 h later
LN cells or DC-enriched LN cells were specifically de-
pleted of human CD41 cells using OKT4 and anti–mouse
IgG–coated magnetic beads, or mock depleted using anti–
mouse IgG–coated beads alone. Responses of the Kb–b-gal
peptide–specific T cell line to these APC populations were
then measured. Mock-depleted total or DC-enriched cells
from mice immunized with either cocoated beads or beads
singly coated with pCMV/b-gal alone, as well as cells from
mice immunized with beads coated with pCMV/b-gal
alone and treated to deplete human CD4-expressing cells,
all retained their full functional activity in stimulating the
CD81 T cells (Fig. 3 B, and data not shown). In contrast,
depletion of cells expressing human CD4 from total or
DC-enriched cell populations obtained from the LNs of
mice immunized with beads cocoated with pCMV/b-gal
and human CD4 plasmids reproducibly reduced presenta-
tion by 60–70%.
Experiments involving in vitro gene gun cotransfection
into B16 melanoma cells with plasmids for GFP and human
CD4 demonstrated coexpression in z70% of the cells ex-
pressing GFP (data not shown). Although these in vitro
data do not provide a direct measure of the extent of effec-
Figure 3. Analysis of APCs in draining LNs presenting the class I–restricted
epitope. Groups of C57BL/6 mice (n 5 4–5) received five abdominal de-
liveries of gold beads coated with different plasmids. 24 h after bombard-
ment, inguinal LN cells were harvested using the collagenase method and
pooled. (A) APCs and control APCs are from mice immunized with
pCMV/b-gal– and mock plasmid–coated particles, respectively. APCs
(106) were depleted of either macrophages, B cells, DEC2051 cells, or
class II1 cells using specific mAbs and magnetic beads as described in Ma-
terials and Methods. Cells then were incubated with 105 T cells specific
for a Kb-restricted b-gal epitope for 18 h in U-bottomed 96-well plates.
IFN-g levels in the supernatants were measured using an ELISA kit, and
results are presented as OD 6 SE. (B) APCs are from mice immunized with
pCMV/b-gal–coated gold beads (b-gal) or from mice immunized with
pCMV/b-gal and T4TM (hCD4 plasmid)–cocoated gold beads
(b-gal1hCD4). APCs (experiment [Exp.] 1, DC-enriched LN cells, 105;
experiment 2, LN cells, 106) were either mock-depleted (i.e., treated only
with magnetic beads) or depleted of cells expressing cell surface hCD4 pro-
tein as described in Materials and Methods (hCD4 dep). Cells were then
incubated with T cells, and IFN-g levels were measured as described
above. Background OD, obtained from T cells without APCs (0.15–
0.19), was subtracted from the results in B. Bars, 6SE. Experiments were
repeated three times with similar results.1080 Presentation by Directly Transfected Dendritic Cells after Gene Gun Vaccination
tive in vivo gene coexpression in DC under these DNA
delivery conditions, they suggest that the coexpression/de-
pletion method will likely underestimate the fraction of
cells expressing an intracellular antigen due to direct trans-
fection. Although B cells are also depleted by the anti–
mouse IgG–coated magnetic beads used to remove hCD41
cells, B cells are not the presenting cells as deduced from
Fig. 3 A and from the observation that depletion only with
anti–mouse IgG–coated magnetic beads or depletion of LN
cells from mice immunized only with b-gal did not affect
presentation (Fig. 3 B). Together, these data imply that di-
rectly transfected DC play a predominant role in presenta-
tion of antigen via MHC class I molecules after gene gun
DNA delivery.
Coexpression of Antigen and DNA-encoded B7.2 Is Essential
for CTL Induction in Conditions that Minimize the Effect of Di-
rect Presentation by Transfected Skin Cells. To further exam-
ine the importance of direct gene transduction of APCs for
in vivo CD81 CTL priming, we turned to a previously de-
scribed model system involving a nonimmunogenic mutant
of influenza nucleoprotein (NPo). The NPo construct is
unable to induce a CTL response on its own due to three
nonconservative mutations near the COOH terminus of
the molecule (F304L, N370S, and R441G). This same mu-
tant protein can elicit CD81 CTL responses when pro-
duced after intramuscular injection of a plasmid also encod-
ing B7.2 (19). However, these previous studies did not
determine whether expression of transfected B7.2 by anti-
gen-presenting muscle cells, antigen-presenting LN cells,
or both was responsible for the observed enhancement of
CTL responses. We revisited this issue by using immuniza-
tion conditions that minimize the effect of direct presenta-
tion by transfected tissue cells. Intramuscular delivery of
DNA results in a relatively consistent expression of the
transfected gene in muscle cells. In contrast, gene bom-
bardment of skin with plasmid DNA results in transient ex-
pression of transfected gene in the skin, peaking at 24 h af-
ter inoculation and largely lost by 3 d after inoculation (16).
Also, antigen-specific T cells stimulated in the draining
LNs are initially retained in the LNs, with efflux of anti-
gen-stimulated T cells from the LNs beginning after 3–4 d
(28). Hence, after one gene gun immunization of the skin,
encounters between antigen-specific naive T cells stimu-
lated in the draining LNs and directly transfected skin cells
are rare. This permitted the design of experiments that
compared the effect on CTL priming of coexpression of
transfected DNA sequences for NPo and B7.2 in individual
cells with that of separate but simultaneous expression of
the two proteins.
Gold beads were coated with either the NPo or the B7.2
plasmids or were cocoated with both plasmids. Mice were
immunized once with overlapping abdominal deliveries of
either the cocoated beads (six shots) or the NPo- and B7.2-
coated beads separately (three shots each). The amount of
gold and the amount of DNA/gene/mouse were standard-
ized so that each mouse received 0.75 mg of each gene
with a total of 3.0 mg of gold beads. The cocoated beads
should allow most individual cells (.70%, based on the in
vitro data) to synthesize both the antigen and the B7.2 co-
stimulatory molecule, whereas separate delivery of the two
plasmids on distinct particles is unlikely to introduce both
DNAs into more than a very small fraction of the trans-
fected cell pool. Fig. 4 shows that overlapping deliveries
with NPo-coated beads and B7.2-coated beads did not
prime for NP-specific CTLs. In contrast, immunization
with the cocoated beads primed for CTLs that specifically
lysed P815 cells pulsed with the NP(147-155) peptide.
These CTLs were as efficient as the CTLs induced by im-
munization with beads coated with colinear vector encod-
ing both NPo and B7.2 (Fig. 4). These data support the re-
sults of the in vitro presentation studies described above in
indicating a predominant role for directly transfected cells
in priming CD81 T cell responses in draining LNs after
gene gun DNA delivery.
This conclusion is consistent with the study by Klinman
et al. noted above (17). In addition, Ciernik et al. demon-
strated that gene gun inoculation with minigenes encoding
class I MHC–restricted T cell epitopes resulted in efficient
induction of CTLs (29). The minigenes encoded cytoplas-
mically expressed CTL epitopes that are not likely to be
secreted and transferred to another cell for class I MHC
presentation, although these results do not exclude presen-
tation by DC after apoptotic cell uptake (30). However,
our data and these previous results contrast with the obser-
vations of Torres et al., who have recently reported that 3 d
Figure 4. CTL responses induced by gene gun delivery of NPo and
B7.2 plasmids. Groups of BALB/c mice were immunized once by gene
gun with a total of six shots, with gold particles either coated with the
colinear construct NPo/B7.2 or cocoated with NPo and B7.2 constructs.
Another set of mice received overlapping shots of gold separately coated
with NPo or B7.2 as described in Materials and Methods. 4 wk after im-
munization, spleens were harvested and restimulated as described in Ma-
terials and Methods. Influenza virus–infected mice were used as positive
controls. Lysis of P815 cells not pulsed with peptide was ,5%. Each point
corresponds to the mean 6 SE obtained from two mice in each group.
The experiment was repeated twice with similar results.1081 Porgador et al.
are required before skin resection at the site of gene gun
bombardment is without effect on priming (16). At pre-
sent, these discrepant results cannot be fully explained, but
may depend on the nature of the plasmid construct, the
encoded antigen, and the method used to evaluate the re-
sponse. It also might reflect DC efflux rate from bom-
barded skin. These considerations bear on the issue of
whether under circumstances other than those studied here
acquisition of antigen from transfected nonhematopoietic
cells may play a more important role in CD81 T cell prim-
ing. The phenomenon of cross-priming is now recognized
as arising from hematopoietic cell (DC) class I MHC mole-
cule presentation of peptides derived from proteins synthe-
sized by other cell types. This pathway has been shown to
play a major role in priming for CTL responses to protein-
coated spleen cells (31), minor H antigen–bearing spleen
cells (32), tumor-associated antigens (33), and responses to
foreign antigens expressed after transfection of myoblasts,
studied as an analogue of intramuscular DNA delivery (34).
However, in the last case, the possibility of direct antigen
expression in DC due to transfer of episomal plasmid DNA
retained by the transfected myoblasts has not been ruled
out. Overall, the preponderance of evidence indicates that
biologically effective presentation of exogenously acquired
foreign protein antigens by DC can occur, perhaps by the
apoptotic cell uptake pathway reported recently (30). Nev-
ertheless, this pathway was not found here to make a sub-
stantial contribution to CD81 T cell priming using gene
gun DNA delivery. A similar conclusion about the impor-
tance of endogenous synthesis of foreign antigen by DC
was also reached in a different model involving expression
of b-gal by recombinant vaccinia viruses (35).
Previous studies have demonstrated the potent T cell
priming capacity of small numbers of antigen-bearing DC
introduced into naive animals (for reviews, see references
36 and 37). The present findings are in agreement with and
amplify these previous results, strongly implying that a few
directly transfected DC are critical for effective CD81 T
cell priming after gene gun DNA immunization. Given
these data, it would seem prudent to explore methods for
enhancing the number of directly transfected DC during
gene gun DNA vaccination, and/or for improving gene
expression within any such transfected DC, as a means of
optimizing the potency of DNA vaccines.
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